Leigh Anderson Launches New Firm to Commercialize SISCAPA Technology
June 17, 2011
Leigh Anderson Launches New Firm to Commercialize SISCAPA Technology
The company, called SISCAPA Assay Technologies, will offer assay development to pharmas and CROs and has tapped antibody firm Epitomics to produce reagents for the system and sell SISCAPA kits. So far, the company has licensed the technology to Pfizer for internal use.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Biocius Buy Key to Agilent's Clinical Proteomics Plans
March 4, 2011 / ProteoMonitor - Targeted Mass Spec Slowly but Steadily Moving Toward Broader Commercial, Clinical Adoption
September 21, 2012 / ProteoMonitor - Hutch, Broad Teams Publish Comprehensive Methods for MS-Based Biomarker Discovery and Verification
July 29, 2011 / ProteoMonitor - Big Names Join Clinical Proteomics Push in 2011, Offering Ray of Optimism Amidst Difficult Year
January 6, 2012 / ProteoMonitor - Agilent Awards Broad's Carr $1.2M in Funding and Equipment to Support Peptide Quantitation Work
October 14, 2011 / ProteoMonitor